As of 12:34:05 PM EST. Market Open. Alector stock falls as the phase II INVOKE-2 study evaluating AL002 in slowing disease progression in early Alzheimer's disease fails to meet the primary goal.
The collaboration deal, which could be worth hundreds of millions of dollars, is a “pivotal moment” for Muna Therapeutics, a ...
AbbVie (ABBV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 3. Analyst Terence Flynn ...
Trump Organization Plans an Ethics Policy Without Banning Foreign Deals The Trump family business is expected to announce some restrictions on transactions, but is not likely to accept as many as ...
A new role awaits Mumbai's iconic Azad Maidan Thursday evening - a decades-old silent witness to the city's turbulent political and socio-cultural history - for, at 5.30 pm, Devendra Fadnavis will ...
Crypto Founders Dominate Finance Category across Forbes’ 30 Under 30 List for 2025 ...